Close

Horizon Pharma (HZNP) Enters Settlement agreement with Express Scripts (ESRX); Will Pay $65M

Go back to Horizon Pharma (HZNP) Enters Settlement agreement with Express Scripts (ESRX); Will Pay $65M

Horizon Pharma plc Provides Update on PBM Formulary Status for Primary Care Medicines

September 29, 2016 8:01 AM EDT

DUBLIN, Ireland, Sept. 29, 2016 (GLOBE NEWSWIRE) -- Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, today announced that it has entered into a rebate agreement with Prime Therapeutics, which secures formulary status for its primary care medicines.  The rebate agreement begins on October 1, 2016. 

Our philosophy is and will continue to be to ensure that patients have access to the medicines their physicians prescribe, said Timothy P. Walbert, chairman, president and chief executive officer.  The... More